Business ethics, fight against corruption and anti-competitive behavior

With regard to the risks related to the issue of “Ethical business management, fight against corruption and anti-competitive behavior,” the rules and standards of conduct with which the Directors and employees of all Group Companies must comply, as must persons or companies acting in the name and on behalf of one or more Group companies, are formalized in the Group Code of Ethics and Model 231 adopted by the parent company.

All Diasorin staff are required to comply with the rules and standards of conduct set out in the Group Code of Ethics, which also specifies the conduct prohibited to prevent episodes of passive corruption – for example the acceptance of gifts or other benefits that may compromise decision-making and judgmental independence.

As a member of the MedTech Europe association, Diasorin has integrated into its code of ethics the provisions of the MedTech Code, which regulates relations between member companies, professionals and healthcare organizations, ensuring that these relationships comply with high ethical standards.

1,014 employees involved in training on ethical issues.

Training of 1,014 employees using specific modules referring to the code of ethics for new hires and periodic training initiatives on current legislation.

Disclosure 205-2 Communication and training about anti-corruption policies and procedures, part of GRI Standard 205: Anti-corruption.